Search Results

Construction of circRNA‐based ceRNA network and its prognosis‐associated subnet of clear cell renal cell carcinoma.

• Authors : Zhang, Yuwei¹ (AUTHOR); Zhang, Yuchen² (AUTHOR); Feng, Yangkun³ (AUTHOR)

• Source: Cancer Medicine. Nov2021, Vol. 10 Issue 22, p8210-8221. 12p.

Record details

CBX2 is a functional target of miRNA let‐7a and acts as a tumor promoter in osteosarcoma.

• Authors : Han, Qicai¹ (AUTHOR); Li, Chao² (AUTHOR); Cao, Yuan³ (AUTHOR)

• Source: Cancer Medicine. Jul2019, Vol. 8 Issue 8, p3981-3991. 11p.

Record details

Induction of resistance to neurotrophic tropomyosin‐receptor kinase inhibitors by HMGCS2 via a mevalonate pathway.

• Authors : Kato, Yasuhiro; Matsumoto, Masaru; Takano, Natsuki

Subjects: STEROL regulatory element-binding proteins; KINASE inhibitors; COLON cancer

• Source: Cancer Medicine; Jun2024, Vol. 13 Issue 12, p1-14, 14p

Record details

Knockdown long noncoding RNA nuclear paraspeckle assembly transcript 1 suppresses colorectal cancer through modulating miR‐193a‐3p/KRAS.

• Authors : Zhu, Zhouting^1,2 (AUTHOR); Du, Shangce³ (AUTHOR); Yin, Kai⁴ (AUTHOR)

• Source: Cancer Medicine. Jan2019, Vol. 8 Issue 1, p261-275. 15p.

Record details

Dysregulated circular RNAs in medulloblastoma regulate proliferation and growth of tumor cells via host genes.

• Authors : Lv, Tao¹; Miao, Yi‐Feng¹; Jin, Ke¹

• Source: Cancer Medicine. Dec2018, Vol. 7 Issue 12, p6147-6157. 11p.

Record details

Cyclin‐dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial‐mesenchymal transition‐like process in glioma by activating TGFβ/SMAD signaling.

• Authors : Feng, Fan^1,2,3 (AUTHOR); Zhao, Zongqing^2,3 (AUTHOR); Cai, Xuechang⁴ (AUTHOR)

• Source: Cancer Medicine. Mar2023, Vol. 12 Issue 5, p5889-5907. 19p.

Record details

Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer.

• Authors : Reza MN; Department of Biotechnology and Genetic Engineering, Life Science Faculty, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.; Mahmud S

Subjects: Helicobacter pylori*/Helicobacter pylori*/Helicobacter pylori*/genetics ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/genetics ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/therapy

• Source: Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 22407-22419. Date of Electronic Publication: 2023 Dec 01.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Blue light induces apoptosis and autophagy by promoting ROS‐mediated mitochondrial dysfunction in synovial sarcoma.

• Authors : Takeuchi, Makoto; Nishisho, Toshihiko; Toki, Shunichi

Subjects: BLUE light; AUTOPHAGY; SYNOVIOMA

• Source: Cancer Medicine; Apr2023, Vol. 12 Issue 8, p9668-9683, 16p

Record details

PIK3R3 is upregulated in liver cancer and activates Akt signaling to control cancer growth by regulation of CDKN1C and SMC1A.

• Authors : Lin W; Department of Hepatobiliary Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of General Surgery, Taizhou Central Hospital (Taizhou University, Hospital), Taizhou, China.

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/genetics ; Proto-Oncogene Proteins c-akt*/Proto-Oncogene Proteins c-akt*/Proto-Oncogene Proteins c-akt*/metabolism; Humans

• Source: Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (13), pp. 14413-14425. Date of Electronic Publication: 2023 May 22.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Androgen receptor knockdown enhances prostate cancer chemosensitivity by down-regulating FEN1 through the ERK/ELK1 signalling pathway.

• Authors : Xie W; Department of Urology and Carson International Cancer Center, Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Center, Shenzhen University, Shenzhen, People's Republic of China.; Li S

Subjects: Receptors, Androgen*/Receptors, Androgen*/Receptors, Androgen*/genetics ; Receptors, Androgen*/Receptors, Androgen*/Receptors, Androgen*/metabolism ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy

• Source: Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (14), pp. 15317-15336. Date of Electronic Publication: 2023 Jun 16.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

Record details